Pharmacovigilance

Direct healthcare professional communication on the importance of adhering to cardiac monitoring guidance during trastuzumab (Herceptin) therapy to reduce the frequency and severity of left ventricular dysfunction and congestive heart failure

24.03.2017

more

Meeting highlights from the PRAC meeting in March 2017

13.03.2017

more

PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations

13.03.2017

more

New review of valproate use in pregnancy and women of childbearing age

13.03.2017

more

EMA reviewing cancer medicines containing docetaxel

13.03.2017

more

Meeting highlights from the CMDh meeting in February 2017

03.03.2017

more

Direct healthcare professional communication on the risk of infections related to the the use of Zydelig (idelalisib)

02.03.2017

more

Meeting highlights from the CHMP meeting in February 2017

28.02.2017

more

SGLT2 inhibitors: information on potential risk of toe amputation to be included in prescribing information

28.02.2017

more

Direct healthcare professional communication on the similarity between names of medicinal products Caprelsa (vandetanib) and Caprez (amlodipine)

21.02.2017

more

For Patients and Public

For Health Care Professionals

For Industry Representatives